Heartflow (NASDAQ:HTFL) Shares Up 2.9% – Here’s What Happened

Heartflow, Inc. (NASDAQ:HTFL) rose 2.9% during trading on Tuesday . The company traded as high as $27.99 and last traded at $27.17. Approximately 84,262 shares changed hands during mid-day trading, a decline of 81% from the average daily volume of 440,757 shares. The stock had previously closed at $26.40.

Analyst Ratings Changes

HTFL has been the subject of a number of research reports. Wall Street Zen upgraded shares of Heartflow to a “hold” rating in a report on Saturday, August 16th. Weiss Ratings assumed coverage on Heartflow in a report on Saturday, November 1st. They issued a “sell (d+)” rating on the stock. Canaccord Genuity Group boosted their target price on Heartflow from $39.00 to $40.00 and gave the stock a “buy” rating in a research report on Thursday, November 13th. Morgan Stanley assumed coverage on Heartflow in a research note on Tuesday, September 2nd. They issued an “equal weight” rating and a $35.00 price target on the stock. Finally, Piper Sandler initiated coverage on shares of Heartflow in a research report on Tuesday, September 2nd. They issued an “overweight” rating and a $38.00 target price on the stock. Four investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $38.60.

Heartflow Stock Performance

The company has a fifty day moving average of $34.44.

Heartflow (NASDAQ:HTFL) last issued its earnings results on Friday, September 19th. The company reported ($1.46) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by ($1.26). The business had revenue of $43.42 million for the quarter, compared to the consensus estimate of $43.20 million.

Institutional Investors Weigh In On Heartflow

Several large investors have recently made changes to their positions in HTFL. TFC Financial Management Inc. bought a new position in Heartflow during the third quarter valued at approximately $40,000. Emerald Mutual Fund Advisers Trust acquired a new position in shares of Heartflow during the 3rd quarter worth $4,418,000. TrueMark Investments LLC acquired a new position in shares of Heartflow during the 3rd quarter worth $918,000. Baillie Gifford & Co. acquired a new stake in shares of Heartflow in the 3rd quarter valued at $101,182,000. Finally, Y Intercept Hong Kong Ltd bought a new stake in Heartflow in the third quarter worth $234,000.

Heartflow Company Profile

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.